Jingjing Ding

430 total citations
19 papers, 286 citations indexed

About

Jingjing Ding is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jingjing Ding has authored 19 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jingjing Ding's work include Pulmonary Hypertension Research and Treatments (3 papers), COVID-19 and healthcare impacts (3 papers) and Peptidase Inhibition and Analysis (2 papers). Jingjing Ding is often cited by papers focused on Pulmonary Hypertension Research and Treatments (3 papers), COVID-19 and healthcare impacts (3 papers) and Peptidase Inhibition and Analysis (2 papers). Jingjing Ding collaborates with scholars based in China, United States and Australia. Jingjing Ding's co-authors include Youjia Yu, Feng Chen, Yanfang Yu, Kwok Yan Li, Huijie Huang, Li Hu, David Fulton, Bin Shen, Dong Wei and Jie Wang and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Cancer Research and Journal of Controlled Release.

In The Last Decade

Jingjing Ding

17 papers receiving 281 citations

Peers

Jingjing Ding
Yumin Ke China
Jingjing Ding
Citations per year, relative to Jingjing Ding Jingjing Ding (= 1×) peers Yumin Ke

Countries citing papers authored by Jingjing Ding

Since Specialization
Citations

This map shows the geographic impact of Jingjing Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Ding more than expected).

Fields of papers citing papers by Jingjing Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingjing Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Ding. The network helps show where Jingjing Ding may publish in the future.

Co-authorship network of co-authors of Jingjing Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Jingjing Ding. A scholar is included among the top collaborators of Jingjing Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingjing Ding. Jingjing Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Huang, Xinmei, Xin Yan, Qiuyan Huang, et al.. (2025). Integrin/CD44-targeted liposomes remodel the pulmonary microenvironment to alleviate acute exacerbation of pulmonary fibrosis. Journal of Controlled Release. 389. 114427–114427.
2.
Zhou, Meng, Jingjing Ding, Qi Lv, et al.. (2025). A UHPLC-Q/TOF-MS/MS-based systematic strategy for analysis of chemical constituents and rat metabolite profiles of modified Shengmai powder. Journal of Pharmaceutical and Biomedical Analysis. 267. 117150–117150.
3.
Ding, Jingjing, et al.. (2024). Consequences of abolishing the COVID-19 zero-tolerance policy in Shanghai: Lessons for future responses. Australian Journal of General Practice. 53(1-2). 78–80. 1 indexed citations
4.
Yang, Xiaowen, et al.. (2024). Factors affecting the use of artificial intelligence generated content by subject librarians: A qualitative study. Heliyon. 10(8). e29584–e29584. 8 indexed citations
5.
Chu, Chunyan, Youjia Yu, Peng Xu, et al.. (2023). Swietenine Alleviates Vascular Remodelling by Enhancing Mitophagy of Pulmonary Arterial Smooth Muscle Cells in Experimental Pulmonary Hypertension. Canadian Journal of Cardiology. 39(5). 646–659. 3 indexed citations
6.
Li, Chenxi, Linjie Zhang, Xuan Chen, et al.. (2023). Evaluation of the genotype I Japanese encephalitis virus as a stable viral vector for foreign gene expression. Antiviral Research. 216. 105652–105652. 4 indexed citations
7.
Ding, Jingjing, et al.. (2022). Research on Classification of Hypertension Patients Based on Pulse Wave. 1–3. 1 indexed citations
8.
Ding, Jingjing, Chunyan Chu, Jiawen Yang, et al.. (2022). Metabolomics-based mechanism exploration of pulmonary arterial hypertension pathogenesis: novel lessons from explanted human lungs. Hypertension Research. 45(6). 990–1000. 6 indexed citations
9.
Hu, Li, Jie Wang, Huijie Huang, et al.. (2021). YTHDF1 Regulates Pulmonary Hypertension through Translational Control of MAGED1. American Journal of Respiratory and Critical Care Medicine. 203(9). 1158–1172. 93 indexed citations
10.
Li, Kwok Yan, Yan Li, Youjia Yu, et al.. (2021). Bmi-1 alleviates adventitial fibroblast senescence by eliminating ROS in pulmonary hypertension. BMC Pulmonary Medicine. 21(1). 80–80. 15 indexed citations
11.
Fan, Jingchun, Jingjing Ding, Jun Zhou, et al.. (2021). The Impact of COVID-19 on Primary Care General Practice Consultations in a Teaching Hospital in Shanghai, China. Frontiers in Medicine. 8. 642496–642496. 25 indexed citations
12.
Connell, William, Jingjing Ding, Ola Niewiadomski, et al.. (2020). Virtually perfect? High patient satisfaction and reduced work absenteeism using a telehealth model of inflammatory bowel disease care during the coronavirus pandemic. Journal of Gastroenterology and Hepatology. 35. 114–114. 1 indexed citations
13.
Li, Kwok Yan, Youjia Yu, Li Ding, et al.. (2020). The histopathological features of the explanted lungs from an end-stage COVID-19 patient. Forensic Sciences Research. 5(4). 348–350. 2 indexed citations
14.
Yu, Youjia, Zishan Gao, Kwok Yan Li, et al.. (2020). Identification of Serum-Based Metabolic Feature and Characteristic Metabolites in Paraquat Intoxicated Mouse Models. Frontiers in Physiology. 11. 65–65. 14 indexed citations
15.
Ding, Jingjing, Chunyan Chu, Juejin Wang, et al.. (2020). Swietenine extracted from Swietenia relieves myocardial hypertrophy induced by isoprenaline in mice. Environmental Toxicology. 35(12). 1343–1351. 5 indexed citations
16.
Fan, Jingchun, Jingjing Ding, Jun Zhou, et al.. (2020). The Impact of COVID-19 on Primary Care General Practice Consultations in a Teaching Hospital in Shanghai, China. SSRN Electronic Journal. 1 indexed citations
17.
Wang, Shouyu, Xuming Wu, Yansu Chen, et al.. (2012). Prognostic and Predictive Role of JWA and XRCC1 Expressions in Gastric Cancer. Clinical Cancer Research. 18(10). 2987–2996. 102 indexed citations
18.
Xu, Jiejie, Renjie Chen, Yuan Mao, et al.. (2011). [Detection of EBV-LMP1 antibodies in sera and clinical significance in the patients with nasopharyngeal carcinoma].. PubMed. 25(9). 401–5. 1 indexed citations
19.
Ye, Manhong, et al.. (2010). Screening of differentially expressed genes inducedby water-soluble extracts from pollen duringhoneybee caste determination. Journal of Animal and Feed Sciences. 19(2). 292–306. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026